CEO LEADERSHIP SERIES
ASHTON TWEED'S CEO INTERVIEWS
January 3, 2017
HOW TO TRANSITION FROM AN R&D TO CLINICAL-STAGE CULTURE During the 11 years that Dr. Elizabeth G. “Tibby” Posillico has been President and CEO of Elusys Therapeutics, […]
November 17, 2016
INVESTING IN THE FUTURE OF CANCER TREATMENT After co-founding and building Morphotek, Inc., a biotech company that specializes in developing biologics for the treatment of oncology, infectious […]
September 26, 2016
HOW WHEN PERSEVERANCE AND PASSION FINALLY PAY OFF When Scott Jackson became CEO of Celator Pharmaceuticals, Inc. more than eight years ago, a new treatment for […]
August 19, 2016
HOW A MERGER JUMP-STARTED A PROMISING DRUG’S DEVELOPMENT Gur Roshwalb, M.D., isn’t afraid of a challenge. When Dr. Roshwalb, CEO of Akari Therapeutics Plc, saw a […]
July 11, 2016
WHY CULTURE IS THE KEY TO A COMPANY’S SUCCESS Dr. Francois Nader knows something about the importance of embracing a culture, whether it’s on a personal […]
May 31, 2016
AN ENTREPRENEURIAL PATHWAY TO LEADERSHIP With an investment and business development background, Kenneth L. Londoner’s career is proof no set or predictable path to running a […]
April 14, 2016
TAKING THE REINS OF A HEALTHCARE TECHNOLOGY INVESTMENT COMPANY French by birth, based in London and doing business in the San Francisco Bay-area biotech community, Dr. […]
March 17, 2016
PASSION FOR PATIENT CARE HELPS BUILD BUSINESS As the CEO of Orthotic Holdings Inc. (OHI), Ivan R. Sabel draws on his experience as both a practitioner […]
January 29, 2016
MAKING CONNECTIONS AND SEIZING OPPORTUNITIES Kathleen P. DeLawrence, Chief Operating Officer of Ability Prosthetics & Orthotics, Inc., has an impressive breadth of experience in the pharmaceutical, […]
December 9, 2015
AFTER DECADES AT MERCK, A NEW ENTREPRENEURIAL BEGINNING After 26 years at Merck & Co. Inc., Graham G. Lumsden was evaluating his career options. He decided […]
October 28, 2015
FROM BIG PHARMA LAYOFF TO LAUNCHING A CRO When Renold J. Capocasale learned that he was being laid off by Johnson & Johnson, where he had […]
September 21, 2015
FROM SEED FUNDING TO FDA APPROVAL IN 20 MONTHS! The biopharmaceutical industry was abuzz earlier this month with the long-awaited launch of Sandoz’ Zarxio™ (filgrastim-sndz), the […]
August 12, 2015
TRANSITIONING FROM SCIENTIST TO CEO By the time he co-founded PDS Biotechnology Corp., a clinical-stage biotech company in North Brunswick, N.J., Dr. Frank K. Bedu-Addo had […]
June 28, 2015
HOW TO REINVENT YOURSELF IN TURBULENT TIMES David Owens is an expert on reinvention and the unconventional path to the C-suite. In 2009, after 30 years in […]
May 15, 2015
THE IMPORTANCE OF BUILDING A STRONG BOARD OF DIRECTORS The composition of a company’s board of directors ultimately can make or break a business. Warren Cooper, […]
ARE YOU A CEO INTERESTED IN JOINING OUR LEADERSHIP SERIES?
CONTACT US TO DISCUSS AN INTERVIEW:
Jordan Warshafsky
Partner, Ashton Tweed Ltd.
Email: JWarshafsky@ashtontweed.com
Phone: 610.725.0290 x441
Ashton Tweed, Ltd.
314 S. Henderson Rd.
Suite G370
King of Prussia, PA 19406